Many but not all prevalent mutations in bladder carcinomas including TP53, KMT2D, ARID1A, KMT2C, PIK3CA and EP300 are more commonly observed in the high TMB group compared with the low TMB group. The gene discussed is KMT2D; the disease is urinary bladder carcinoma.